HK1108835A1 - Octenidine-containing lozenges used against inflammatory oral and pharyngeal diseases - Google Patents

Octenidine-containing lozenges used against inflammatory oral and pharyngeal diseases

Info

Publication number
HK1108835A1
HK1108835A1 HK07114030.6A HK07114030A HK1108835A1 HK 1108835 A1 HK1108835 A1 HK 1108835A1 HK 07114030 A HK07114030 A HK 07114030A HK 1108835 A1 HK1108835 A1 HK 1108835A1
Authority
HK
Hong Kong
Prior art keywords
octenidine
used against
oral
pharyngeal
against inflammatory
Prior art date
Application number
HK07114030.6A
Inventor
Holger Miething
Original Assignee
Divapharma Knufinke Arzneimittelwerk Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Divapharma Knufinke Arzneimittelwerk Gmbh filed Critical Divapharma Knufinke Arzneimittelwerk Gmbh
Publication of HK1108835A1 publication Critical patent/HK1108835A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to a lozenge, especially based on caramel, which is suitable for the topical treatment of inflammatory oral and pharyngeal diseases. Said lozenge contains octenidine, preferably in the form of octenidine dihydrochloride, as an active substance such that a therapeutically effective amount of octenidine, preferably octenidine dihydrochloride, is released during sucking when the lozenge is administered and sucked in a patient's oral and pharyngeal cavity.
HK07114030.6A 2004-10-12 2007-12-21 Octenidine-containing lozenges used against inflammatory oral and pharyngeal diseases HK1108835A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004049798 2004-10-12
DE102004052308A DE102004052308B4 (en) 2004-10-12 2004-10-28 Octenidine-containing lozenges against inflammatory diseases of the mouth and throat
PCT/EP2005/008973 WO2006039961A1 (en) 2004-10-12 2005-08-19 Octenidine-containing lozenges used against inflammatory oral and pharyngeal diseases

Publications (1)

Publication Number Publication Date
HK1108835A1 true HK1108835A1 (en) 2008-05-23

Family

ID=35149087

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07114030.6A HK1108835A1 (en) 2004-10-12 2007-12-21 Octenidine-containing lozenges used against inflammatory oral and pharyngeal diseases

Country Status (15)

Country Link
EP (1) EP1799186B1 (en)
CN (1) CN101052373B (en)
AT (1) ATE398441T1 (en)
DE (2) DE102004052308B4 (en)
EA (1) EA011991B1 (en)
ES (1) ES2309790T3 (en)
GE (1) GEP20094809B (en)
HK (1) HK1108835A1 (en)
HR (1) HRP20080438T3 (en)
NO (1) NO20071795L (en)
PL (1) PL1799186T3 (en)
RS (1) RS50593B (en)
SI (1) SI1799186T1 (en)
UA (1) UA83320C2 (en)
WO (1) WO2006039961A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101842085B (en) 2007-10-31 2013-01-30 麦克内尔-Ppc股份有限公司 Orally disintegrated dosage form
RU2497679C2 (en) 2008-10-02 2013-11-10 Милан Инк. Method of making multilayer adhesive laminated material
EP2201951A1 (en) * 2008-11-14 2010-06-30 Ahmet Melih Aydinoglu Octenidine composition
US9610224B2 (en) 2009-09-24 2017-04-04 Johnson & Johnson Consumer Inc. Manufacture of tablet in a die utilizing powder blend containing water-containing material
US20110318411A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
PL2701681T3 (en) 2011-04-29 2017-03-31 Moberg Pharma Ab Pharmaceutical compositions comprising a local anaesthetic such as bupivacaine for local administration to the mouth or throat
DE102012000976A1 (en) * 2012-01-20 2013-07-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Composition for topical treatment
DE102012007212A1 (en) * 2012-04-11 2013-10-17 Merz Pharma Gmbh & Co. Kgaa Preparation for topical application to mucous membranes with polyhexanide as active ingredient
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
DE202013000446U1 (en) * 2012-10-04 2013-10-07 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Composition, in particular pharmaceutical composition, in particular for administration in hoarseness and sore throat
MX368159B (en) 2014-01-10 2019-09-20 Johnson & Johnson Consumer Inc Process for making tablet using radiofrequency and lossy coated particles.
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210386A (en) * 1983-12-09 1987-11-27 Sterling Drug Inc Saccharine salts and dentrifice compositions
AU7204787A (en) * 1986-03-17 1987-10-09 Oral Research Laboratories, Inc. Treatment of dental surfaces with plaque retardants
GB9204410D0 (en) * 1992-02-29 1992-04-15 Smithkline Beecham Plc Method of treatment
US6350438B1 (en) * 1998-02-27 2002-02-26 The Procter & Gamble Company Oral care compositions comprising chlorite and methods
DE10026716A1 (en) * 2000-05-30 2001-12-13 Ferton Holding Sa Prophylactic mouthwash solution, especially for use together with an abrasive powder, comprises an antimicrobial or bacteriostatic and tooth-remineralizing agent
PT1294383E (en) * 2000-06-30 2008-10-08 Procter & Gamble Oral compositions comprising antimicrobial agents for the prevention of systemic diseases
DE10205883A1 (en) * 2002-02-13 2003-08-21 Schuelke & Mayr Gmbh Aqueous antiseptic based on bispyridiniumalkanes

Also Published As

Publication number Publication date
CN101052373A (en) 2007-10-10
RS50593B (en) 2010-05-07
EA200700777A1 (en) 2007-10-26
HRP20080438T3 (en) 2008-10-31
DE102004052308B4 (en) 2013-04-04
ES2309790T3 (en) 2008-12-16
NO20071795L (en) 2007-07-06
UA83320C2 (en) 2008-06-25
ATE398441T1 (en) 2008-07-15
EP1799186B1 (en) 2008-06-18
DE102004052308A1 (en) 2006-04-13
GEP20094809B (en) 2009-10-26
EA011991B1 (en) 2009-06-30
DE502005004475D1 (en) 2008-07-31
WO2006039961A1 (en) 2006-04-20
SI1799186T1 (en) 2008-10-31
CN101052373B (en) 2010-06-16
EP1799186A1 (en) 2007-06-27
PL1799186T3 (en) 2008-11-28

Similar Documents

Publication Publication Date Title
HK1108835A1 (en) Octenidine-containing lozenges used against inflammatory oral and pharyngeal diseases
WO2002069945A3 (en) Novel medicament compositions on the basis of anticholinergics and pde iv inhibitors
YU71901A (en) NOVEL MEDICAMENT COMPOSITIONS, BASED ON ANTICHOLINERGICALLY EFFECTIVE COMPOUNDS AND beta-MIMETICS
SG169233A1 (en) Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
RS20090105A (en) Medicament compositions based on tiotropium salts and on salmetrol salts
DE60126923D1 (en) THERAPEUTIC COMPOSITIONS COMPRISING ANTI-HYPOTENSIVA AND ANTIANGIOGENICA
ZA200408649B (en) Opthamological use of roflumilast for the treatment of diseases of the eye
NO20031019L (en) Sustained oxymorphone release formulations
IL172705A (en) Use of 4-(2-chloroethyl)-1-((2-cyclohexen-1-yl)hydroxymethyl)-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione and its esters in the manufacture of medicaments
HK1102991A1 (en) Pharmaceutical formulation of decitabine
BR0312573A (en) Phenyl- [4- (3-phenyl-1h-pyrazol-4-yl) -pyrimidin-2-yl] -amine derivatives
WO2008022256A3 (en) Methods and compositions for preventing or treating age-related diseases
CY1107465T1 (en) MELAGATRANI FOR THERAPEUTIC INFECTION
SE0102276D0 (en) Device and method for administering a drug
CA2503810A1 (en) Therapeutic agent for fibromyalgia
DE602005021115D1 (en) METHOD AND COMPOSITIONS FOR ORAL FTS DELIVERY
ATE413187T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING INTERFERON TAU
WO2006079910A3 (en) 0-(3-piperidino-2hydroxypropyl)nicotinic amixodime for treating lesions in the oral cavity
SE0004101D0 (en) New use
SE9902597D0 (en) New use
WO2001074396A8 (en) Composition and method for promoting oral health
WO2004105759A3 (en) Novel long-acting medicament combinations comprising an anticholinergic agent and a $g(b)2-adrenoreceptor antagonist for the treatment of respiratory tract diseases
NZ542305A (en) Treatment of proliferative diseases with an epothilone derivative and radiation
WO2004073627A3 (en) Novel therapeutic method and compositions for topical administration
JO2586B1 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140819